Digital Technology Linked to Lower Rates of Cognitive Decline in Adults Older Than 50
By Elana Gotkine HealthDay Reporter
THURSDAY, April 17, 2025 -- Widespread use of digital technology seems to be associated with lower rates of cognitive decline in adults older than 50 years, according to a study published online April 14 in Nature Human Behaviour.
Jared F. Benge, Ph.D., from the University of Texas at Austin, and Michael K. Scullin, Ph.D., from Baylor University in Waco, Texas, conducted a systematic review and meta-analysis to examine whether technological exposure has helped or harmed cognition in digital pioneers. Fifty-seven observational or cohort studies focusing on general digital technology use in older adults (older than 50 years) were included in the meta-analysis; 411,430 adults were included from cross-sectional and longitudinal observational studies.
The researchers found an association for use of digital technologies with a reduced risk for cognitive impairment (odds ratio, 0.42) as well as reduced time-dependent rates of cognitive decline (hazard ratio, 0.74). When accounting for demographic, socioeconomic, health, and cognitive reserve proxies, the effects remained significant.
"Technology engagement was associated with reduced odds of cognitive decline in middle-aged and older adults," the authors write. "There was no credible evidence from the longitudinal studies, or the meta-analysis as a whole, for widespread digital 'brain drain' or 'digital dementia' as a result of general, natural uses of digital technology."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
MONDAY, July 21, 2025 -- For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1...
Gabapentin for Back Pain Linked to Increased Risk for Dementia, MCI
FRIDAY, July 11, 2025 -- For adults with chronic low back pain, gabapentin prescription is associated with an increased risk for dementia and mild cognitive impairment (MCI)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.